AstraZeneca to Scrap Plan for U.S. Covid Booster Study

AstraZeneca Plc is dropping plans to test its Covid-19 vaccine as a booster in the U.S., according to a letter sent to participants in the clinical trial that urged volunteers to seek a third dose elsewhere. After discussions with the U.S. government, it became clear that the U.K. drugmaker was unlikely to pursue plans to assess a third dose of its vaccine, New York’s Montefiore Medical Center to

Read more at: https://www.bloombergquint.com/onweb/astra-to-scrap-plan-for-u-s-booster...
Copyright © BloombergQuint